WES Pharma Inc is a dynamic and emerging specialty pharmaceutical company focused on developing and manufacturing difficult to develop, technology-driven specialty generics for the US markets. WES nurtures the entire product lifecycle-from the early stages of R&D through U.S. Food and Drug Administration (FDA) approval and manufacturing the approved product. WES’s professional team of scientists has expertise in developing multitude of dosage forms. WES develops majority of its products in-house in addition to partnering with other pharmaceutical companies to synergize development, manufacturing, and marketing capabilities. WES’s business model is to develop complex generic and innovative specialty pharmaceutical products in oral solids and liquids forms.
There is no investment information
No recent news or press coverage available for WES Pharma Inc.
We care about your data, and we'd love to use cookies make your experience better.
